Dr. Ira H. Kirschenbaum, MD

Dr. Kirschenbaum practices at BronxCare Ambulatory Care Network in Bronx, New York.

Dr. Kirschenbaum's NPI, 1396723482, was assigned on January 9, 2006. Dr. Kirschenbaum graduated from Albert Einstein College of Medicine of Yeshiva University in 1984. Dr. Kirschenbaum holds New York license 162874.

Dr. Kirschenbaum's primary practice is BronxCare Ambulatory Care Network, at 1650 Grand Concourse FL 14, Bronx, NY 10457 in Bronx County. The practice phone is (718) 518-5000.

Dr. Kirschenbaum's primary practice is BronxCare Ambulatory Care Network in Bronx, New York. Dr. Kirschenbaum is also affiliated with BronxCare Hospital Center. The medical group on file is BronxCare Health System. Dmand AI also links Dr. Kirschenbaum to 1 more breast imaging center, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kirschenbaum practices, 4 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Kirschenbaum's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Kirschenbaum is licensed in New York.

CMS data shows 60 Medicare services from Dr. Kirschenbaum across 2 procedure codes in 2024, for 55 Medicare patients. Medicare paid $3,115 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 55 Medicare patients who saw Dr. Kirschenbaum in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have arthritis, and 75% have high blood pressure. 69% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kirschenbaum's median patient age at 64, with 73% women.

In 2024, Dr. Kirschenbaum wrote 366 Medicare Part D claims for 107 patients. 96% of them were for generic drugs. CMS names the drug for 325 of them, across 3 drugs with 11 or more claims each, at $3,286 in total drug cost. In 2023, CMS named 244 claims across 5 drugs.

Dr. Kirschenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Kirschenbaum, published from 2018 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Arthroplasty, Replacement, Emergency Service, Hospital and Hospitals, Urban. Dr. Kirschenbaum has published most often in J Am Acad Orthop Surg Glob Res Rev. Dr. Kirschenbaum's most frequent co-authors are Morteza Meftah, MD and Ahmed Siddiqi, DO.

CMS Open Payments shows 141 general payments to Dr. Kirschenbaum from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 32% of the total. Pacira Pharmaceuticals Incorporated paid the most, $24,633.

Dr. Kirschenbaum graduated from Albert Einstein College of Medicine of Yeshiva University in 1984.